Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 289

1.

Quantitative and qualitative changes in DES-related neointimal tissue based on serial OCT.

Kim JS, Hong MK, Shin DH, Kim BK, Ko YG, Choi D, Jang Y.

JACC Cardiovasc Imaging. 2012 Nov;5(11):1147-55. doi: 10.1016/j.jcmg.2012.01.024.

PMID:
23153915
[PubMed - indexed for MEDLINE]
Free Article
2.

Optical coherence tomographic comparison of neointimal coverage between sirolimus- and resolute zotarolimus-eluting stents at 9 months after stent implantation.

Kim JS, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Aug;28(6):1281-7. doi: 10.1007/s10554-011-9943-x. Epub 2011 Aug 21.

PMID:
21858655
[PubMed - indexed for MEDLINE]
3.

Evaluation of long-term follow-up with neointimal coverage and stent apposition after sirolimus-eluting stent implantation by optical coherence tomography.

Li S, Gai L, Yang T, Zhang L, Xu X, Bai Q, Xu H, Wang Y.

Catheter Cardiovasc Interv. 2013 Apr;81(5):768-75. doi: 10.1002/ccd.24497. Epub 2012 Jul 23.

PMID:
22639418
[PubMed - indexed for MEDLINE]
4.

Optical coherence tomography findings of very late stent thrombosis after drug-eluting stent implantation.

Ko YG, Kim DM, Cho JM, Choi SY, Yoon JH, Kim JS, Kim BK, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Apr;28(4):715-23. doi: 10.1007/s10554-011-9905-3. Epub 2011 Jun 8.

PMID:
21656060
[PubMed - indexed for MEDLINE]
5.

Favorable neointimal coverage in everolimus-eluting stent at 9 months after stent implantation: comparison with sirolimus-eluting stent using optical coherence tomography.

Choi HH, Kim JS, Yoon DH, Hong KS, Kim TH, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Mar;28(3):491-7. doi: 10.1007/s10554-011-9849-7. Epub 2011 Mar 26.

PMID:
21442265
[PubMed - indexed for MEDLINE]
6.

Long-term (≥2 years) follow-up optical coherence tomographic study after sirolimus- and paclitaxel-eluting stent implantation: comparison to 9-month follow-up results.

Kim TH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2011 Jul;27(6):875-81. doi: 10.1007/s10554-010-9729-6. Epub 2010 Oct 27.

PMID:
20978851
[PubMed - indexed for MEDLINE]
7.

Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial.

Kim JS, Jang IK, Fan C, Kim TH, Kim JS, Park SM, Choi EY, Lee SH, Ko YG, Choi D, Hong MK, Jang Y.

JACC Cardiovasc Interv. 2009 Dec;2(12):1240-7. doi: 10.1016/j.jcin.2009.10.006.

PMID:
20129551
[PubMed - indexed for MEDLINE]
Free Article
8.

Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.

Fujino Y, Attizzani GF, Bezerra HG, Wang W, Tahara S, Yamamoto H, Chamie D, Kanaya T, Mehanna E, Takagi K, Nakamura S, Costa MA.

JACC Cardiovasc Interv. 2013 Oct;6(10):1035-45. doi: 10.1016/j.jcin.2013.05.015.

PMID:
24156964
[PubMed - indexed for MEDLINE]
9.

Stent strut coverage of titanium-nitride-oxide coated stent compared to paclitaxel-eluting stent in acute myocardial infarction: TITAX-OCT study.

Lehtinen T, Airaksinen KE, Ylitalo A, Karjalainen PP.

Int J Cardiovasc Imaging. 2012 Dec;28(8):1859-66. doi: 10.1007/s10554-012-0032-6. Epub 2012 Feb 24.

PMID:
22362097
[PubMed - indexed for MEDLINE]
10.

Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis.

Hou J, Jia H, Liu H, Han Z, Yang S, Xu C, Schmitt J, Zhang S, Yu B, Jang IK.

Int J Cardiovasc Imaging. 2012 Dec;28(8):1879-86. doi: 10.1007/s10554-012-0031-7. Epub 2012 Mar 16.

PMID:
22422037
[PubMed - indexed for MEDLINE]
11.

Initial findings of impact of strut width on stent coverage and apposition of sirolimus-eluting stents assessed by optical coherence tomography.

Nakatani S, Nishino M, Taniike M, Makino N, Kato H, Egami Y, Shutta R, Tanouchi J, Yamada Y.

Catheter Cardiovasc Interv. 2013 Apr;81(5):776-81. doi: 10.1002/ccd.24401. Epub 2012 May 24.

PMID:
22517601
[PubMed - indexed for MEDLINE]
12.

Two-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Endeavor zotarolimus-eluting stent.

Nishinari M, Shimohama T, Tojo T, Shiono T, Shinagawa H, Kameda R, Aoyama N, Izumi T.

Catheter Cardiovasc Interv. 2013 Dec 1;82(7):E871-8. doi: 10.1002/ccd.25136. Epub 2013 Aug 17.

PMID:
23873677
[PubMed - indexed for MEDLINE]
13.

Long-term vascular healing in response to sirolimus- and paclitaxel-eluting stents: an optical coherence tomography study.

Räber L, Baumgartner S, Garcia-Garcia HM, Kalesan B, Justiz J, Pilgrim T, Moschovitis A, Khattab AA, Buellesfeld L, Wenaweser P, Meier B, Serruys PW, Jüni P, Windecker S.

JACC Cardiovasc Interv. 2012 Sep;5(9):946-57. doi: 10.1016/j.jcin.2012.05.012. Erratum in: JACC Cardiovasc Interv. 2012 Nov;5(11):1192. Garcia, Hector M Garcia [corrected to Garcia-Garcia, Hector M].

PMID:
22995882
[PubMed - indexed for MEDLINE]
Free Article
14.

Head-to-head comparison of the neointimal response between metallic and bioresorbable everolimus-eluting scaffolds using optical coherence tomography.

Gomez-Lara J, Brugaletta S, Farooq V, Onuma Y, Diletti R, Windecker S, Thuesen L, McClean D, Koolen J, Whitbourn R, Dudek D, Smits PC, Chevalier B, Regar E, Veldhof S, Rapoza R, Ormiston JA, Garcia-Garcia HM, Serruys PW.

JACC Cardiovasc Interv. 2011 Dec;4(12):1271-80. doi: 10.1016/j.jcin.2011.08.016.

PMID:
22192368
[PubMed - indexed for MEDLINE]
Free Article
15.

Optical coherence tomography-based evaluation of malapposed strut coverage after drug-eluting stent implantation.

Kim BK, Shin DH, Kim JS, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Dec;28(8):1887-94. doi: 10.1007/s10554-012-0039-z. Epub 2012 Mar 25.

PMID:
22447206
[PubMed - indexed for MEDLINE]
16.

Comparison of zotarolimus-eluting stent and everolimus-eluting stent for vascular healing response: serial 3-month and 12-month optical coherence tomography study.

Kim SJ, Lee H, Cho JM, Park CB, Kim W, Kato K, Yonetsu T, Kim CJ, Jang IK.

Coron Artery Dis. 2013 Aug;24(5):431-9. doi: 10.1097/MCA.0b013e328362b2e7.

PMID:
23722649
[PubMed - indexed for MEDLINE]
17.

Optical coherence tomography assessment of in vivo vascular response after implantation of overlapping bare-metal and drug-eluting stents.

Guagliumi G, Musumeci G, Sirbu V, Bezerra HG, Suzuki N, Fiocca L, Matiashvili A, Lortkipanidze N, Trivisonno A, Valsecchi O, Biondi-Zoccai G, Costa MA; ODESSA Trial Investigators.

JACC Cardiovasc Interv. 2010 May;3(5):531-9. doi: 10.1016/j.jcin.2010.02.008.

PMID:
20488410
[PubMed - indexed for MEDLINE]
Free Article
18.

Very long-term follow-up of strut apposition and tissue coverage with Biolimus A9 stents analyzed by optical coherence tomography.

Staico R, Costa MA, Chamié D, Bezerra H, Armaganijan LV, Costa RA, Costa JR, Siqueira D, Centemero M, Chaves Á, Tanajura LF, Abizaid A, Feres F, Sousa JE, Sousa AG.

Int J Cardiovasc Imaging. 2013 Jun;29(5):977-88. doi: 10.1007/s10554-013-0188-8. Epub 2013 Mar 3.

PMID:
23456358
[PubMed - indexed for MEDLINE]
19.

Major determinants for the uncovered stent struts on optical coherence tomography after drug-eluting stent implantation.

Kim BK, Kim JS, Oh C, Ko YG, Choi D, Jang Y, Hong MK.

Int J Cardiovasc Imaging. 2012 Apr;28(4):705-14. doi: 10.1007/s10554-011-9896-0. Epub 2011 May 31.

PMID:
21626042
[PubMed - indexed for MEDLINE]
20.

Comparison of early strut coverage between zotarolimus- and everolimus-eluting stents using optical coherence tomography.

Kim S, Kim JS, Shin DH, Kim BK, Ko YG, Choi D, Cho YK, Nam CW, Hur SH, Jang Y, Hong MK.

Am J Cardiol. 2013 Jan 1;111(1):1-5. doi: 10.1016/j.amjcard.2012.08.037. Epub 2012 Oct 2.

PMID:
23040589
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk